Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MACK | CGEN | KROS | ||
| Company | Merrimack Pharmaceuticals Inc | Compugen Ltd | Keros Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 15.15 | 2.35 | 11.15 | ||
| High | 15.17 | 2.41 | 11.18 | ||
| Low | 15.13 | 2.35 | 10.80 | ||
| Last | 15.13 | 2.35 | 10.77 | ||
| Change | unch | -0.06 | -0.38 | ||
| Percent Change | unch | -2.49% | -3.41% | ||
| Volume | 1,255,700 | 88,676 | 47,479 | ||
| 20-Day Average Volume | 396,880 | 235,821 | 194,036 | ||
| Previous | 15.13 | 2.41 | 11.15 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.95 | 2.35 | 10.40 | ||
| 20-Day Raw Stochastic | 92.47% | 58.57% | 78.66% | ||
| 20-Day Relative Strength | 74.45 | 51.98 | 52.88 | ||
| Weighted Alpha | +23.43 | +51.00 | -30.95 | ||
| Today's Opinion | 100% Buy | 40% Buy | 64% Sell | ||
| Yesterday's Opinion | 100% Buy | 48% Buy | 48% Sell | ||
| Last Month's Opinion | 80% Buy | 56% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 05/10/24 | -0.21% since 08/03/26 | +8.06% since 08/03/26 | ||
| Low | 15.10 on 05/13/24 | 2.26 on 08/05/26 | 9.69 on 08/04/26 | ||
| High | 15.16 on 05/17/24 | 2.44 on 08/04/26 | 11.26 on 08/07/26 | ||
| 1-Month | |||||
| %Chg | +3.07% since 04/17/24 | -0.63% since 07/10/26 | -7.42% since 07/10/26 | ||
| Low | 14.67 on 04/18/24 | 2.17 on 08/03/26 | 9.69 on 08/04/26 | ||
| High | 15.16 on 05/17/24 | 2.52 on 07/21/26 | 11.78 on 07/13/26 | ||
| 3-Month | |||||
| %Chg | +2.93% since 02/16/24 | -18.10% since 05/08/26 | -9.49% since 05/08/26 | ||
| Low | 14.60 on 03/12/24 | 1.95 on 06/10/26 | 9.69 on 08/04/26 | ||
| High | 15.16 on 05/17/24 | 3.05 on 05/14/26 | 12.21 on 05/11/26 | ||
| 6-Month | |||||
| %Chg | +18.02% since 11/17/23 | +34.94% since 02/10/26 | -36.30% since 02/10/26 | ||
| Low | 12.54 on 11/30/23 | 1.63 on 02/12/26 | 9.69 on 08/04/26 | ||
| High | 15.89 on 02/13/24 | 3.23 on 04/24/26 | 17.17 on 02/12/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 223,742 | 227,873 | 221,071 | ||
| Shares Outstanding, K | 14,788 | 94,553 | 19,827 | ||
| Annual Sales, $M | 0 | 72,760,000 | 244,060,000 | ||
| Annual Net Income, $M | -1,180,000 | 35,340,000 | 87,010,000 | ||
| Last Qtr Sales, $M | 0 | 2,180,000 | 370,000 | ||
| Last Qtr Income, $M | -240,000 | -7,670,000 | -23,710,000 | ||
| 60-Month Beta | 1.45 | 2.77 | 0.99 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 05/15/24 | -0.07 on 08/03/26 | -1.45 on 08/03/26 | ||
| Latest Earnings Date | 08/01/24 | 11/09/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | 05/30/17 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.05 | 0.00 | ||